ATE153697T1 - Mycobakterium polypeptide und dafür kodierende nukleinsäuren zur diagnose und kontrolle von tuberkulose - Google Patents

Mycobakterium polypeptide und dafür kodierende nukleinsäuren zur diagnose und kontrolle von tuberkulose

Info

Publication number
ATE153697T1
ATE153697T1 AT92903939T AT92903939T ATE153697T1 AT E153697 T1 ATE153697 T1 AT E153697T1 AT 92903939 T AT92903939 T AT 92903939T AT 92903939 T AT92903939 T AT 92903939T AT E153697 T1 ATE153697 T1 AT E153697T1
Authority
AT
Austria
Prior art keywords
nucleic acids
tuberculosis
diagnosis
control
acids coding
Prior art date
Application number
AT92903939T
Other languages
English (en)
Inventor
Jean Content
Lucas De Wit
Jacqueline De Bruyn
Original Assignee
Innogenetics Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8208544&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE153697(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Innogenetics Nv filed Critical Innogenetics Nv
Application granted granted Critical
Publication of ATE153697T1 publication Critical patent/ATE153697T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Gram-positive bacteria
    • C07K16/1289—Mycobacteriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT92903939T 1991-02-14 1992-02-07 Mycobakterium polypeptide und dafür kodierende nukleinsäuren zur diagnose und kontrolle von tuberkulose ATE153697T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91400388A EP0499003A1 (de) 1991-02-14 1991-02-14 Polypeptide und Peptide, insbesondere rekombinante Polypeptide und Peptide, dafür kodierende Nukleinsäuren und Verwendung dieser Polypeptide und Peptide in der Tuberkulosediagnose

Publications (1)

Publication Number Publication Date
ATE153697T1 true ATE153697T1 (de) 1997-06-15

Family

ID=8208544

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92903939T ATE153697T1 (de) 1991-02-14 1992-02-07 Mycobakterium polypeptide und dafür kodierende nukleinsäuren zur diagnose und kontrolle von tuberkulose

Country Status (12)

Country Link
US (2) US5955356A (de)
EP (2) EP0499003A1 (de)
JP (1) JPH06504909A (de)
AT (1) ATE153697T1 (de)
AU (1) AU659822B2 (de)
CA (1) CA2104111C (de)
DE (1) DE69220042T3 (de)
DK (1) DK0571420T4 (de)
ES (1) ES2103928T5 (de)
GR (1) GR3024408T3 (de)
IL (1) IL100938A0 (de)
WO (1) WO1992014823A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6991797B2 (en) 1993-07-02 2006-01-31 Statens Serum Institut M. tuberculosis antigens
DK79793D0 (da) * 1993-07-02 1993-07-02 Statens Seruminstitut Diagnostic test
US7300660B2 (en) 1993-11-23 2007-11-27 The Regents Of The University Of California Abundant extracellular products and methods for their production and use
JPH09505588A (ja) 1993-11-23 1997-06-03 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 多くの細胞外生成物及びそれらの製造法並びに使用
US6752993B1 (en) 1993-11-23 2004-06-22 The Regents Of The University Of California Abundant extracellular product vaccines and methods for their production and use
EP1091004B1 (de) * 1994-06-24 2009-02-25 Innogenetics N.V. Gleichzeitiger Nachweis, Identifizierung und Differenzierung von Mykobakterium Spezies unter Verwendung eines Hybridisierungs-Assays
WO1996005223A1 (en) * 1994-08-12 1996-02-22 The Regents Of The University Of California Abundant extracellular products and methods for their production and use
US5736524A (en) 1994-11-14 1998-04-07 Merck & Co.,. Inc. Polynucleotide tuberculosis vaccine
US5935568A (en) * 1995-05-18 1999-08-10 National Jewish Medical & Research Center Gene therapy for effector cell regulation
AU6260796A (en) * 1995-06-07 1996-12-30 National Jewish Center For Immunology And Respiratory Medicine Isolated formylated bacterial peptides, nucleic acid molecul es and uses thereof
US6592877B1 (en) 1995-09-01 2003-07-15 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6338852B1 (en) 1995-09-01 2002-01-15 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
US6290969B1 (en) 1995-09-01 2001-09-18 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6458366B1 (en) 1995-09-01 2002-10-01 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
US6013660A (en) * 1996-10-02 2000-01-11 The Regents Of The University Of California Externally targeted prophylactic and chemotherapeutic method and agents
US6982085B2 (en) 1997-04-02 2006-01-03 Statens Serum Institut TB diagnostic based on antigens from M. tuberculosis
US7037510B2 (en) 1997-04-18 2006-05-02 Statens Serum Institut Hybrids of M. tuberculosis antigens
GB9714242D0 (en) * 1997-07-07 1997-09-10 Mini Agriculture & Fisheries Glycosylation peptides
US6291190B1 (en) * 1998-08-25 2001-09-18 The Board Of Trustees Of The Leland Stanford Junior University Molecular differences between species of the M. tuberculosis complex
US6465633B1 (en) 1998-12-24 2002-10-15 Corixa Corporation Compositions and methods of their use in the treatment, prevention and diagnosis of tuberculosis
WO2000073345A2 (en) * 1999-05-28 2000-12-07 Promega Corporation Antibodies specific for mycobacterial polypeptides and uses thereof
GB0006693D0 (en) * 2000-03-20 2000-05-10 Glaxo Group Ltd Vaccine
WO2002004018A2 (en) * 2000-07-10 2002-01-17 Colorado State University Research Foundation Mid-life vaccine and methods for boosting anti-mycobacterial immunity
US20050267025A1 (en) * 2002-02-01 2005-12-01 Ho John L Compositions and methods for treatment of infectious and inflammatory diseases
US20030199012A1 (en) * 2002-02-01 2003-10-23 Ho John L. Compositions and methods for treatment of infectious and inflammatory diseases
BRPI0518933A2 (pt) 2004-11-16 2008-12-16 Crucell Holland B V E Aeras Gl adenovÍrus recombinante defeituoso de replicaÇço, vetor de polinucleotÍdeo recombinante, vacina multivalente da tuberculose, e, uso do antÍgeno tb10.4 de mycobacterium
US20120321656A1 (en) * 2011-06-20 2012-12-20 Matthias Rath Oligopeptides and their use for treating infectious diseases
US20140349320A1 (en) * 2011-12-15 2014-11-27 The Trustees Of The University Of Pennsylvania Using Adaptive Immunity to Detect Drug Resistance
US11313338B1 (en) * 2020-11-20 2022-04-26 Caterpillar Inc. Method and system for monitoring injector valves

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264550A (en) * 1985-04-15 1993-11-23 Scios Nova Inc. Human anti-inflammatory phospholipase inhibitor protein
US4689397A (en) * 1985-08-12 1987-08-25 Scripps Clinic And Research Foundation Synthetic polypeptides for detecting mycobacterial infections
WO1990010701A1 (en) * 1989-03-08 1990-09-20 Commonwealth Scientific And Industrial Research Organisation Expression system for actinomycetes and related organisms
FR2645878B1 (fr) * 1989-04-17 1994-02-25 Institut Nal Sante Recherc Medic Sequences nucleotidiques d'actinomycetales, applications a la synthese ou a la detection d'acides nucleiques, produits d'expression de ces sequences et application en tant que compositions immunogenes

Also Published As

Publication number Publication date
CA2104111C (en) 2008-01-08
JPH06504909A (ja) 1994-06-09
DK0571420T4 (da) 2005-06-20
ES2103928T3 (es) 1997-10-01
DK0571420T3 (da) 1997-12-29
AU659822B2 (en) 1995-06-01
WO1992014823A1 (en) 1992-09-03
EP0571420A1 (de) 1993-12-01
GR3024408T3 (en) 1997-11-28
DE69220042D1 (de) 1997-07-03
CA2104111A1 (en) 1992-08-15
US5955356A (en) 1999-09-21
EP0571420B2 (de) 2005-03-16
EP0571420B1 (de) 1997-05-28
US6638511B1 (en) 2003-10-28
ES2103928T5 (es) 2005-09-01
AU1223492A (en) 1992-09-15
DE69220042T3 (de) 2005-12-01
DE69220042T2 (de) 1997-12-11
IL100938A0 (en) 1992-11-15
EP0499003A1 (de) 1992-08-19

Similar Documents

Publication Publication Date Title
DE69220042D1 (de) Mycobakterium polypeptide und dafür kodierende nukleinsäuren zur diagnose und kontrolle von tuberkulose
DE68929467D1 (de) HIV-2 Varianten
IL95742A (en) Recombinant polypeptides and peptides nucleic acids coding for the same and use of these polypeptides and peptides in the diagnosis of tuberculosis
DK0776209T3 (da) Polynukleinsyrer og proteiner fra et porcin reproduktiv og respiratorisk syndrom-virus og anvendelser deraf
ATE274578T1 (de) Von menschlichen t-zellen immunodominante epitopen des virus der c-hepatitis
SE8901687D0 (sv) Fibronectin binding protein as well as its preparation
ZA921230B (en) Improved activation of recombinant proteins
NO895028L (no) Ny chimerisk transformerende vekstfaktor-beta.
SE8702272L (sv) Fibronektinbindande protein samt dess framstaellning
ATE121754T1 (de) Vakzine gegen bordetella.
ATE72710T1 (de) Datenaustauschsystem mit benutzerterminal und chipkarte.
ATE89155T1 (de) Geraet zur wiederherstellung eines gliedes.
DE3377220D1 (en) Recombinant dna, microorganism transformed therewith and use thereof
DE69231940D1 (de) Rekombinant DNS kodierend für eine Endochitinase
ATE122055T1 (de) Dna- und rna-moleküle des westlichen subtyps des fsme-virus, polypeptide, die von diesen molekülen codiert werden, und deren verwendung.
DE69739071D1 (de) Menschliche tak1 und für diese kodierende dna
AU5315790A (en) Molecules containing at least one peptide sequence carrying one or several epitopes characteristic of a protein produced by p. falciparum at the sporozoite stage and in the hepatocytes
ATE98962T1 (de) Menschliche rhinoviruspeptide.
ES2179060T3 (es) Plasmido derivado de lactobacillus delbrueckii sp.
DE3688643D1 (de) Fuer eine variante des elongationsfaktors 2 kodierende dns-sequenz.
DE60138885D1 (de) Polypeptide mit aktivität der stimulierung von neutrophilen
DE69221708D1 (de) Neue Translationsaktivierungssequenz
TH43867A (th) ลำดับกรดนิวคลีอิคและกรดอะมิโนที่เกี่ยวข้องกับ Helicobacter pyroli และองค์ประกอบวัคซีนของมัน

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0571420

Country of ref document: EP

REN Ceased due to non-payment of the annual fee